Q3 results anticipation — Bayer price forecast signals 1.73% gain amid mixed momentum
Bayer AG (BAYN) is currently trading at $27.28, showing a daily gain of $0.47 or 1.73%. The price remains below both the MA-20 at $27.80 and MA-50 at $27.76, but is well supported above the MA-200 at $24.88, signaling near-term pressure but ongoing long-term support.
36.33
36.39
Highlights
- Bayer AG (BAYN) gained 1.73% to $27.28 but remains below its MA-20 at $27.80 and MA-50 at $27.76, signaling near-term resistance.
- The Q3 results in November are expected to confirm lower EBITDA and earnings per share forecasts, making them a key short-term catalyst for BAYN.
- With mixed momentum indicators and resistance at $28.25, BAYN is likely to trade between $26.36 and $26.63 over the next five days, with sub-20% rally odds.
Earnings forecasts drive sentiment ahead of November results
Bayer is set to report its Q3 results in November, with the market closely watching for confirmation of lower EBITDA and earnings per share forecasts. This earnings release is seen as a key driver for the stock in the short term. No other major company-specific developments were reported.
Mixed momentum and resistance as technical boundaries dictate range
The price is encountering resistance at the Kijun level of $28.25, with the MA-50 at $27.76 also acting as a ceiling. Technical support holds at $26.76, while the MA-200 at $24.88 provides longer-term backing. Momentum indicators are mixed: MACD and ADX are neutral, RSI reads 42.49 and CCI is –126.54, both hinting at short-term oversold conditions. The BBP indicator shows intraday downside control, but today's close near the high points to some recoveries amid subdued volatility.
Limited rally prospects as consolidation and range risks persist
Over the next five trading days, BAYN is expected to trade between $26.36 and $26.63. The chances of another significant rally remain low — under 20% — and sideways consolidation within the current range is likely. Should resistance at $28.25 be breached, upside potential opens, but if support at $26.76 is lost, a move toward $26.36 could follow.
Latest Bayer News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
